Paul L Durham Selected Research

Paul L Durham Research Topics

Disease

32	Migraine Disorders (Migraine) 03/2024 - 04/2002
11	Inflammation (Inflammations) 03/2024 - 01/2008
9	Temporomandibular Joint Disorders (Temporomandibular Joint Disorder) 01/2022 - 01/2006
8	Pain (Aches) 12/2023 - 01/2012
4	Ganglion Cysts (Ganglion) 08/2017 - 07/2007
4	Headache (Headaches) 11/2011 - 02/2003
3	Neurogenic Inflammation 06/2006 - 04/2002
2	Chronic Pain 11/2020 - 07/2010
2	Rhinosinusitis 01/2009 - 01/2006
1	Dysbiosis 03/2024
1	Headache Disorders (Headache Syndromes) 11/2020
1	Neoplasms (Cancer) 08/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Arthralgia (Joint Pain) 01/2015
1	Osteoarthritis 01/2015
1	Dysmenorrhea (Menstrual Pain) 05/2010
1	Allergic Rhinitis 01/2009
1	Sinusitis 01/2009
1	Infections 01/2004
1	Botulism 01/2004
1	Paralysis (Palsy) 01/2004
1	Vascular Headaches (Vascular Headache) 02/2003

Drug/Important Bio-Agent (IBA)

21	Calcitonin Gene-Related PeptideIBA 07/2023 - 04/2002
14	NeuropeptidesIBA 12/2022 - 04/2002
7	Sumatriptan (Imigran)FDA LinkGeneric 01/2020 - 04/2002
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2007
5	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 12/2021 - 03/2004
4	Peptides (Polypeptides)IBA 07/2023 - 07/2004
4	Grape Seed ExtractIBA 12/2022 - 12/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2017 - 06/2006
3	CytokinesIBA 01/2015 - 01/2009
3	Tryptamines (Triptans)IBA 01/2013 - 01/2004
3	Type A Botulinum Toxins (Botox)FDA Link 01/2013 - 01/2004
2	Freund's AdjuvantIBA 08/2022 - 08/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 04/2006
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2018 - 08/2017
2	Capsules (Microcapsules)IBA 03/2017 - 07/2007
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2016 - 04/2010
2	CalciumIBA 12/2016 - 02/2003
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 08/2015 - 01/2006
2	Naproxen (Naprosyn)FDA LinkGeneric 01/2012 - 05/2010
2	olcegepantIBA 07/2010 - 07/2004
2	rizatriptan (Maxalt)FDA Link 10/2009 - 01/2004
2	Capsaicin (Zostrix)FDA Link 01/2009 - 07/2007
2	true blueIBA 01/2009 - 07/2007
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 09/2008 - 07/2004
1	Volatile Fatty AcidsIBA 03/2024
1	AntioxidantsIBA 03/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024
1	PolyphenolsIBA 03/2024
1	Phytosterols (Plant Sterols)IBA 03/2024
1	(1R,5S)- 4- methyl- 1- propan- 2- ylbicyclo(3.1.0)hex- 3- en- 2- oneIBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	LigandsIBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	AntibodiesIBA 12/2021
1	Neuroprotective AgentsIBA 12/2020
1	Morphine (MS Contin)FDA LinkGeneric 11/2020
1	Opioid Analgesics (Opioids)IBA 11/2020
1	Analgesics (Analgesic Drugs)IBA 11/2020
1	KT 5720IBA 08/2017
1	Coloring Agents (Dyes)IBA 12/2016
1	diamidino compound 253-50IBA 12/2016
1	Glial Fibrillary Acidic ProteinIBA 12/2016
1	Protons (Proton)IBA 01/2013
1	preemptIBA 11/2011
1	NeurotoxinsIBA 11/2011
1	Dihydroergotamine (Agit)FDA LinkGeneric 10/2010
1	telcagepantIBA 07/2010
1	TabletsIBA 05/2010
1	ProstaglandinsIBA 05/2010
1	p38 Mitogen-Activated Protein KinasesIBA 04/2010
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2010
1	EnzymesIBA 04/2010
1	Phosphotransferases (Kinase)IBA 04/2010
1	tonabersatIBA 01/2009
1	ConnexinsIBA 11/2008
1	Topiramate (Topamax)FDA LinkGeneric 09/2006
1	Pseudoephedrine FDA LinkGeneric 01/2006
1	beta-Galactosidase (Lactaid)IBA 01/2004
1	eletriptan (Relpax)FDA Link 01/2004
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2004
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2004
1	Serotonin (5 Hydroxytryptamine)IBA 04/2002

Therapy/Procedure

10	Therapeutics 08/2015 - 04/2002
3	Vagus Nerve Stimulation 11/2020 - 11/2017
1	Mind-Body Therapies 08/2015
1	Drug Therapy (Chemotherapy) 06/2006
1	Aftercare (After-Treatment) 02/2003